Day: August 31, 2024

FuelPositive Closes Final Tranche of Private Placement

Written by Customer Service on . Posted in Public Companies.

WINNIPEG, Manitoba and WATERLOO, Ontario, Aug. 31, 2024 (GLOBE NEWSWIRE) — FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (the “Company”) announces that it has closed a non-brokered private placement (the “Offering”) and has issued 8,925,055 units (each, a “Unit”) at a price of $0.055 per Unit for gross proceeds of $490,878.  Each “Unit” consists of one common share of the Company, and one common share purchase warrant exercisable at a price of $0.07 until August 29, 2029.  The Offering represents the final tranche of the placement previously announced by the Company on May 28, 2024. No finders’ fees or commissions were paid in connection with completion of the Offering.  All securities issued in connection with the Offering are subject to restrictions on resale until December 30, 2024 in accordance with applicable...

Continue reading

Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

SHANGHAI, Aug. 30, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its 2024 interim financial results and provided corporate updates. FINANCIAL HIGHLIGHTS As of June 30, 2024, the total revenue of Junshi Biosciences was approximately RMB786 million during the first half of 2024, representing an increase of approximately 17% compared to 2023. The growth was mainly due to the approximately 11% increase in revenue from pharmaceutical products compared to 2023. In particular, the domestic sales revenue of our core product, TUOYI® (toripalimab), reached approximately RMB671 million, representing an increase of approximately 50%...

Continue reading

Medivolve Announces Management Changes

Written by Customer Service on . Posted in Public Companies.

TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) — Medivolve Inc. (“Medivolve” or the “Company”) (OTC: MEDVF; FRA: 4NC) announces today that David Preiner has resigned from his position as president and chief executive officer of the Company, effective August 26, 2024. Mr. Preiner will continue to support the Company in his capacity as a consultant. The board and management thanks Preiner for his service and contributions and wish him well in his future endeavours. About Medivolve Medivolve is a Canadian healthcare technology company headquartered in Toronto, Canada. The Company’s mission is to improve health and lives by delivering world-class diagnostic solutions—starting with COVID-19—as well as to enable faster and better care to patients through innovative technology. Medivolve, through its subsidiaries, operates retail patient-care...

Continue reading

Victory Square Technologies Reports Q2 2024 Financial Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Revenue for the six-months ended June 30, 2024 was $7,993,311, an increase of 46% compared to Q2, 2023 VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company that gives investor access to a portfolio of 25+ innovative companies from around the world in a single stock, announces it has filed its Consolidated Financial Statements for the six-months ended June 30th, 2024 along with its Management Discussion and Analysis (MD&A). Company: Victory Square is a Venture Builder that provides investors a liquid way to invest in early-stage technology companies without buying a venture fund that requires accredited investor status or multi-year commitments. A diverse portfolio of 25+ innovative companies from around...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.